IDEAYA Biosciences
Aaron Albers is a seasoned medicinal chemist with extensive experience across various prominent biotechnology companies. Currently serving as a Senior Principal Scientist at IDEAYA Biosciences since May 2024, Albers has previously held roles such as Associate Director at Ambagon Therapeutics and Principal Scientist at IDEAYA Biosciences. Additional experience includes positions as Senior Scientist I and Scientist II at Plexxikon Inc. and Senior Research Scientist at Catalent Pharma Solutions, along with a postdoctoral fellowship at The Molecular Foundry. Albers earned a PhD in Chemistry from the University of California, Berkeley, and a BS in Chemistry from UC San Diego.